DARE Dare Bioscience, Inc.

$0.71▲ +0.13% Healthcare Other
After hours $0.71▼ -0.14% Sep 11, 7:42 PM ET
Volume 92.7K Avg Volume (10D) 315.1K
Key Metrics & Fundamentals
Market Cap
$13.89M
P/E Ratio
–
Div Yield
–%
52W Range
0.69 - 3.78
% vs 50 MA
-43.61%
% vs 200 MA
-60.74%
RSI-14
27.0
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.03
Free Cash Flow
-$6.86M
Gross Rev
$187,546
Gross Profit
-$132,343
EBITDA
-$2.40M
COGS
$319,889
Operating Exp
$2.84M
Operating Income
-$2.97M
EBIT
-$2.97M
Pretax Income
-$2.98M
Net Income
-$2.98M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
GlobeNewswire · Sep 11, 2026 10:55 AM
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
GlobeNewswire · Aug 31, 2026 12:44 PM
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
GlobeNewswire · Aug 27, 2026 1:01 PM
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
GlobeNewswire · Aug 26, 2026 12:45 PM
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
GlobeNewswire · Aug 25, 2026 12:55 PM
Daré Bioscience (DARE) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 8:55 PM
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List
GlobeNewswire · Aug 18, 2026 1:02 PM
Dare Bioscience Inc (DARE) (Q2 2026) Earnings Call Highlights: Commercial Launch Milestones and ...
GuruFocus.com · Aug 17, 2026 8:34 PM
Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall
MT Newswires · Aug 14, 2026 5:25 PM
Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire · Aug 14, 2026 4:45 PM
Financial Overview - Income Statement Quarterly

See DARE's money flow as a full page

Social Sentiment
Avg -0.14 · 24 posts
DiscussionTradeTIL there is already a double-leveraged SpaceX ETF. I dare you to buy it. For fuck's sake, is this really necessary?
r/wallstreetbets · Jun 16, 2026
The comments express strong disapproval and question the necessity of the ETF, indicating a bearish sentiment towards the investment.
negative -0.80
AVGO has fallen so sharply, but I see a massive rebound to $400! Stop looking at those junk AI stocks; AVGO is the real AI arms dealer!
r/stocks · Dec 16, 2025
The author expresses a bullish outlook on AVGO, highlighting its strong client base and financial performance.
positive +0.60
AI isn’t dead, but Wall Street just stopped buying the dream. We’re entering the ‘cash flow era.
r/stocks · Dec 11, 2025
The post expresses concerns about high capital expenditures and revenue expectations, suggesting a shift away from ‘dream driven’ valuations which could negatively impact DARE's stock.
negative -0.50
DiscussionMemeBiting the hand that feeds you
r/wallstreetbets · Nov 16, 2025
The post expresses a pessimistic view of DARE's situation, using terms like 'hole,' 'last nail in the coffin,' and 'desperation,' reflecting a bearish sentiment.
negative -0.60
TradeDiscussionRegional banks
r/wallstreetbets · Oct 17, 2025
The post expresses concern about holding a leveraged ETF during market uncertainty, indicating a negative outlook.
negative +0.60
Page 1 of 5 (24 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙